Internet Delivered Cognitive Rehabilitation for Mild Cognitive Impairments
Launched by ANIKO BARTFAI · May 7, 2025
Trial Information
Current as of August 20, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
When broadly defined, diseases and injuries affecting the central nervous system are one of the leading causes of disease burden in the world affecting more than 3 billion people. With such a large proportion of the global population affected, optimization of limited resources in the form of specialized rehabilitation is instrumental to ensuring sustainable public health.
The consequences of acquired brain injuries (ABIs) and neurological disorders are multifaceted, causing diminished functional capacity in a range of areas. Cognitive impairments are common, affecting ability to work, take...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Enrolled in community neurorehabilitation in Stockholm, Sweden
- • Mild to moderate cognitive impairment as a consequence of acquired brain injury or nervous system disease
- • MoCA 21 ≥
- • Sufficient command of Swedish language
- • Access to internet connected device and internet connection
- Exclusion Criteria:
- • Severe and enduring psychiatric or behavioural disorders (i.e Schizophrenia, substance abuse)
- • Suspected or diagnosed dementia
- • Homelessness or other social instability rendering access to internet unpredictable
About Aniko Bartfai
Aniko Bartfai is a distinguished clinical trial sponsor dedicated to advancing medical research through innovative and rigorous study designs. With a strong focus on translational medicine, the organization collaborates with leading academic institutions and industry partners to facilitate the development of novel therapeutics. Aniko Bartfai's commitment to ethical research practices and patient-centered approaches ensures the highest standards of safety and efficacy in clinical trials, ultimately aiming to improve patient outcomes and contribute to the scientific community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stockholm, , Sweden
Patients applied
Trial Officials
Aniko Bartfai, PhD
Principal Investigator
Karolinska Institutet Danderyds Sjukhus (KIDS), Department of medical rehabilitation
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported